Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Trading Statement

3 Oct 2011 07:00

RNS Number : 3414P
Tarsus Group PLC
03 October 2011
 



Tarsus Group plc

3 October 2011

Disposal of French Joint Venture

and

Trading Update

Modamont - France

 

Tarsus Group plc ('Tarsus', the 'Group' or the 'Company'), the international business-to-business media group, is pleased to announce that it has reached agreement to dispose of its 51 per cent. interest in the joint venture, Modamont SAS ("Modamont"), to its joint venture partner, Premiere Vision SAS, for a total consideration of €6.1 million (the "Disposal").

 

Modamont is the leading exhibition for fashion accessories in France and takes place bi-annually in Paris in February and September. In the year ended 31 December 2010 Tarsus's 51 per cent. share of Modamont revenues and profits were approximately €2.2 million and €0.6 million respectively. Tarsus's share of Modamont's net assets were approximately €0.7 million as at 30 September 2011. Tarsus's share of Modamont's gross assets as at 30 June 2011 were approximately €1.5 million. At completion, Tarsus France SAS will repay a loan of €2.2 million to Modamont. The net proceeds from the Disposal will be used to give additional flexibility to the Company's balance sheet.

 

Owing to its significant shareholding in Modamont, Premiere Vision is considered to be a related party for the purposes of the Listing Rules and the Disposal therefore constitutes a related party transaction. Consequently, the Disposal is subject to and conditional upon the approval of shareholders in the Company at a general meeting. Further details of the Disposal and a notice convening a general meeting to approve the Disposal will be sent to Tarsus shareholders in due course.

 

Trading Update

 

Since the announcement of the Group's interim results on 27 July 2011, the Group has held three major exhibitions. Off Price took place in Las Vegas in August 2011 and generated a like-for-like revenue increase of approximately 6 per cent. Modamont and Labelexpo Europe (the second largest show in the Group's portfolio, held in Brussels) both took place in September and produced like-for-like revenue increases of 9 per cent. and over 10 per cent. respectively, both slightly ahead of management's expectations. The Group's largest event in the fourth quarter, the Dubai Airshow, is on track to meet management's expectations.

 

Forward bookings continue to be strong and the Board is increasingly confident of good progress being made this year.

 

Douglas Emslie, Group Managing Director of Tarsus, commented:

 

"The disposal of Modamont will materially reduce our exposure to the lower growth European market and less than 10 per cent. of Group profits will now be generated from France. Tarsus France will continue to focus on its remaining wholly owned portfolio of exhibitions.

 

We now have greater financial flexibility to accelerate our drive into the faster growth emerging markets where we are actively pursuing potential acquisitions. As we continue to execute our growth strategy we anticipate a further significant increase in the proportion of our business coming from the emerging markets".

 

For further information, please contact:

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director 020 8846 2700

Dan O'Brien, Group Finance Director 020 8846 2700

 

Media

Madano Partnership:

Matthew Moth 020 7593 4000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUROSRAVAKOAR
Date   Source Headline
9th May 20134:53 pmRNSBlocklisting Interim Review
30th Apr 20135:56 pmRNSHolding(s) in Company
30th Apr 20135:09 pmRNSTotal Voting Rights
30th Apr 20135:09 pmRNSDirector/PDMR Shareholding
17th Apr 20137:15 amRNSAnnual Financial Report
15th Apr 20134:55 pmRNSDirector/PDMR Shareholding
10th Apr 20132:36 pmRNSDirector/PDMR Shareholding
3rd Apr 20135:15 pmRNSDirector/PDMR Shareholding
3rd Apr 201311:49 amRNSTotal Voting Rights and Capital
18th Mar 20136:00 pmRNSHolding(s) in Company
8th Mar 20135:22 pmRNSDirector/PDMR Shareholding
6th Mar 20137:00 amRNSFinal Results
1st Mar 20137:00 amRNSCompletion of Indonesian Acquisition
19th Feb 201310:12 amRNSNotice of Results
30th Jan 20137:30 amRNSAdditional Listing
16th Jan 20137:00 amRNSIndonesian Acquisition
14th Jan 20134:25 pmRNSDirector Declaration
7th Jan 20137:00 amRNSTrading Statement
2nd Jan 20135:09 pmRNSDirector/PDMR Shareholding
20th Dec 20124:00 pmRNSScrip dividend circular
18th Dec 20127:00 amRNSBoard Changes: Non-executive director roles
17th Dec 20127:00 amRNSCompletion of joint venture with GZ Auto
30th Nov 20122:37 pmRNSTotal Voting Rights
15th Nov 20127:00 amRNSInterim Management Statement
9th Nov 20123:25 pmRNSBlocklisting Interim Review
6th Nov 20122:23 pmRNSCompletion of Acquisition
31st Oct 20124:18 pmRNSTotal Voting Rights
25th Oct 20127:00 amRNSAcquisition
17th Oct 201212:08 pmRNSApplication for Admission
28th Sep 20123:25 pmRNSTotal Voting Rights
11th Sep 20121:45 pmRNSInterim Financial Statements 2012
7th Sep 20127:00 amRNSSite Visit
5th Sep 20124:40 pmRNSDirector/PDMR Shareholding
31st Aug 20122:39 pmRNSTotal Voting Rights
20th Aug 20124:13 pmRNSDirector/PDMR Shareholding
25th Jul 20127:00 amRNSHalf Yearly Report
12th Jul 20127:00 amRNSApplication for Admission
6th Jul 201210:08 amRNSNotice of Results
4th Jul 20121:41 pmRNSResult of AGM
29th Jun 20127:00 amRNSPre-Close Trading Statement
28th Jun 20124:40 pmRNSSecond Price Monitoring Extn
28th Jun 20124:35 pmRNSPrice Monitoring Extension
18th Jun 20127:00 amRNSCirc re. Scrip Dividend
15th May 20127:00 amRNSInterim Management Statement
9th May 20124:11 pmRNSBlocklisting Six Monthly Return
9th May 20124:05 pmRNSAnnual Information Update
3rd May 20125:06 pmRNSDirector/PDMR Shareholding
30th Apr 20124:53 pmRNSTotal Voting Rights
25th Apr 20123:42 pmRNSAnnual Report & Accounts and Notice of 2012 AGM
25th Apr 20127:00 amRNSChinese Joint Venture

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.